Biosceptre is proud to announce that lead scientists Alex Joechner and Dr. Cindy Li from the Biosceptre Laboratory were honoured with an invitational oral presentation at the European Hematology Association (EHA) 2025 Annual Congress, held this week in Milan.
With more than 14,000 delegates in attendance, EHA is one of the world’s premier events for hematological research. Of the more than 3,500 abstracts submitted last year, only 235 were selected for oral presentation—highlighting the exceptional quality and impact of the work presented by our team.
The 15-minute oral presentation showcased compelling new data on Biosceptre’s modular CAR-T platform, focusing on its function and therapeutic potential in treating Acute Myeloid Leukemia (AML). This recognition reflects the scientific strength of our BRiDGECAR™ program and the dedication of our team in advancing next-generation cell therapies for challenging blood cancers.
We congratulate Alex and Dr. Li on this achievement and thank the EHA for the opportunity to present on the global stage.